Global Drug Delivery Devices Market – Industry Trends - Forecast to 2026

  • Pharmaceutical
  • Upcoming Reports
  • Mar 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Drug Delivery Devices Market By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Drug Delivery Devices Market

Global Drug Delivery Devices Market is expected to rise from its initial estimated value of USD 1243.34 billion in 2018 to a projected value of USD 2070.12 billion by 2026, registering a CAGR of 6.58% in the forecast period of 2019-2026. This rise in market value can be attributed to the constant innovations and advancements in the market resulting in product launches.

Market Definition: Global Drug Delivery Devices Market

Drug delivery devices are those medical devices and equipments that are used for dispatching the drugs into the human bodies and various systems. They are specifically made for dispatching the specific drugs according to the various administration techniques. These devices are used for the therapeutic treatments and entire recovery procedure.

Market Drivers:

  • Increasing prevalence of chronic diseases globally resulting in increased consumption of therapeutic drugs and therapies; this factor is expected to act as a driver for the market growth
  • Growth in the consumption of drugs and therapeutic pharmaceuticals because of the development and better nature of treatment associated with these drugs; this factor is expected to act as a driver for the market growth

Market Restraint:

  • Increase in complications and expertise required in delivering therapeutics and drugs through these devices; this factor is expected to act as a restraint to the market growth

Segmentation: Global Drug Delivery Devices Market

  • By Route of Administration

    • Oral Drug Delivery

      • Solid Oral Drugs

        • Tablets
        • Capsules
        • Powders
        • Pills

      • Liquid Oral Drugs

        • Syrups
        • Solutions

      • Semi-Solid Oral Drugs

        • Gels
        • Emulsions
        • Elixirs

    • Injectable Drug Delivery

      • Conventional Injection Devices (By Material)

        • Glass
        • Plastic

      • Conventional Injection Devices (By Product)

        • Fillable Syringes
        • Pre-Filled Syringes

      • Conventional Injection Devices (By Usability)

        • Reusable Syringes
        • Disposable Syringes

      • Self-Injection Devices

        • Needle-Free Injectors
        • Autoinjectors
        • Pen Injectors
        • Wearable Injectors

      • Other Injector Devices

    • Topical Drug Delivery

      • Liquid Formulations

        • Solutions
        • Suspensions

      • Semi-Solid Formulations

        • Creams
        • Gels
        • Ointments
        • Pastes
        • Lotions

      • Solid Formulations

        • Suppositories
        • Powders

      • Transdermal Products

        • Transdermal Patches
        • Transdermal Gels

    • Ocular Drug Delivery

      • Liquid Formulations

        • Eye Drops
        • Liquid Sprays

      • Semi-Solid Formulations

        • Gels
        • Eye Ointments

      • Ocular Devices

        • Drug-Coated Contact Lenses
        • Ocular Inserts

    • Pulmonary Drug Delivery

      • Metered-Dose Inhalers
      • Dry Powder Inhalers
      • Nebulizers

        • Jet Nebulizers
        • Ultrasonic Nebulizers
        • Soft Mist Nebulizers

    • Nasal Drug Delivery

      • Nasal Drops
      • Nasal Sprays
      • Nasal Powders
      • Nasal Gels

    • Transmucosal Drug Delivery

      • Oral Formulations

        • Buccal Drug Delivery
        • Sublingual Drug Delivery

      • Others

        • Rectal Transmucosal Drug Delivery
        • Vaginal Transmucosal Drug Delivery

    • Implantable Drug Delivery

      • Active Implantable Drug Delivery
      • Passive Implantable Drug Delivery

  • By Patient Care Setting

    • Hospitals
    • Diagnostic Centers
    • Ambulatory Surgery Centers/Clinics
    • Home Care Settings
    • Others

  • By Application

    • Cancer
    • Infectious Diseases
    • Respiratory Diseases
    • Diabetes
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Central Nervous System Disorders
    • Others

      • Endocrine Disorders
      • Ophthalmic Disorders

  • By Geography

    • North America

      • US.
      • Canada
      • Mexico

    • South America

      • Brazil
      • Argentina
      • Rest of South America

    • Europe

      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe

    • Asia-Pacific

      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia Pacific

    • Middle East & Africa

      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa

Key Developments in the Market:

  • In September 2018, Sulzer Ltd announced that they had completed the acquisition of MEDMIX SYSTEMS AG. This acquisition will help Sulzer Ltd in expanding their business segments to include the healthcare division and help in providing various products for the healthcare market.
  • In July 2018, Gerresheimer AG announced that they had acquired Sensile Medical and has expanded their service portfolios through this acquisition. This acquisition will help in expanding the technological portfolio of Gerresheimer AG due to Sensile’s expertise in the development and usage of liquid drug delivery devices.

Competitive Analysis: Global Drug Delivery Devices Market

Global drug delivery devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drug delivery devices market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Drug Delivery Devices Market

BD.; F. Hoffmann-La Roche Ltd; Antares Pharma; Novartis AG; 3M; Sulzer Ltd; Gerresheimer AG; Sanofi; Johnson & Johnson Services, Inc.; Bayer AG; GlaxoSmithKline plc; Novosanis; MEDMIX SYSTEMS AG; Merck & Co., Inc.; Pfizer Inc.; Insulet Corporation; OraSure Technologies, Inc.; Enable Injections; West Pharmaceutical Services, Inc.; SMC Ltd.; ViVO Smart Medical Devices Ltd. and Cipla Inc. are few of the major competitors currently present in the market.

Research Methodology: Global Drug Delivery Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report:

  • Current and future of global drug delivery devices market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

SKU-

1. INTRODUCTION

       1.1. OVERVIEW OF THE DRUG DELIVERY DEVICES MARKET
       1.2. CURRENCY AND PRICING
       1.3. LIMITATION
       1.4. MARKETS COVERED

2. RESEARCH METHODOLOGY

       2.1. MARKETS IN DRUG DELIVERY DEVICES MARKET
       2.2. GEOGRAPHICAL SCOPE
       2.3. YEARS CONSIDERED IN THE STUDY
       2.4. CURRENCY AND PRICING
       2.5. RESEARCH METHODOLOGY
                2.5.1. MARKET CRACKDOWN APPROACH
                2.5.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
                2.5.3. DATA TRIANGULATION
       2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
       2.7. SECONDARY SOURCES
       2.8. ASSUMPTIONS

3. MARKET OVERVIEW

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

       6.1. OVERVIEW
       6.2. ORAL DRUG DELIVERY, BY FORM
                6.2.1. SOLID ORAL DRUGS, BY PRODUCT TYPE
                           6.2.2.1. TABLETS
                           6.2.2.2. CAPSULES
                           6.2.2.3. POWDER
                           6.2.2.4. PILLS
                6.2.2. LIQUID ORAL DRUGS, BY PRODUCT TYPE
                           6.2.2.1. SOLUTIONS
                           6.2.2.2. SYRUPS
                6.2.3. SEMI SOLID ORAL DRUGS, BY PRODUCT TYPE
                           6.2.3.1. GELS
                           6.2.3.2. EMULSIONS
                           6.2.3.3. ELIXIRS
       6.3. PULMONARY DRUG DELIVERY, BY PRODUCT TYPE
                6.3.1. METERED DOSE INHALERS (MDI)
                6.3.2. DRY POWDER INHALERS (DPI)
                6.3.3. NEBULIZERS
                           6.3.3.1. JET NEBULIZERS
                           6.3.3.2. ULTRASONIC NEBULIZERS
                           6.3.3.3. SOFT MIST NEBULIZERS
       6.4. INJECTABLE DRUG DELIVERY, BY PRODUCT TYPE
                6.4.1. INJECTABLE DRUG DELIVERY DEVICES, BY PRODUCT TYPE
                           6.4.1.1. CONVENTIONALS INJECTABLES, BY MATERIAL
                                         6.4.1.1.1. GLASS
                                         6.4.1.1.2. PLASTIC
                           6.4.2.2. CONVENTIONALS INJECTABLES, BY PRODUCT TYPE
                                         6.4.2.2.1. FILLABLE
                                         6.4.2.2.2. PRE-FILLED
                           6.4.3.3. CONVENTIONALS INJECTABLES, BY USABILITY
                                         6.4.3.3.1. REUSABLE SYRINGES
                                         6.4.3.3.2. DISPOSABLE SYRINGES
                           6.4.3.4. SELF INJECTION DEVICES
                           6.4.3.5. NEEDLE FREE INJECTORS
                           6.4.3.6. AUTO-INJECTORS
                           6.4.3.7. PEN INJECTORS
                           6.4.3.8. WEARABLE INJECTORS
                           6.4.3.9. OTHERS
                6.4.2. INJECTABLES DRUG DELIVERY FORMULATIONS, BY PRODUCT TYPE
                           6.4.2.1. CONVENTIONAL DRUG DELIVERY FORMULATIONS
                           6.4.2.2. NOVEL DRUG DELIVERY FORMULATIONS
                           6.4.2.3. LONG ACTING INJECTION FORMULATIONS
       6.5. OPTHALMIC DRUG DELIVERY, BY PRODUCT TYPE
                6.5.1. OCCULAR DRUG DELIVERY DEVICES, BY PRODUCT TYPE
                           6.5.1.1. DRUG COATED CONTACT LENSES
                           6.5.1.2. OCCULAR INSERTS
                           6.5.2. OCCULAR DRUG DELIVERY FORMULATIONS, BY FORM
                           6.5.2.1. LIQUID OCCULAR DRUG DELIVERY FORMULATIONS, BY TYPE
                                         6.5.2.1.1. EYE DROPS
                                         6.5.2.1.2. SPRAYS
                           6.5.2.2. SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS, BY TYPE
                                         6.5.2.2.1. GELS
                                         6.5.2.2.2. OINTMENTS
       6.6. NASAL DRUG DELIVERY, BY PRODUCT TYPE
                6.6.1. NASAL DROPS
                6.6.2. NASAL SPRAYS
                6.6.3. NASAL POWDERS
                6.6.4. NASAL GELS
       6.7. TOPICAL DRUG DELIVERY, BY PRODUCT TYPE
                6.7.1. TRANSDERMAL DRUG DELIVERY DEVICES, BY PRODUCT TYPE
                           6.7.1.1. TRANSDERMAL PATCHES
                           6.7.1.2. TRANSDERMAL GELS
                6.7.2. TOPICAL DRUG DELIVERY FORMULATIONS, BY FORM
                           6.7.2.1. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE
                                         6.7.2.1.1. SOLUTIONS
                                         6.7.2.1.2. SUSPENSIONS
                           6.7.2.2. SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE
                                         6.7.2.2.1. GELS
                                         6.7.2.2.2. CREAMS
                                         6.7.2.2.3. OINTMENTS
                                         6.7.2.2.4. PASTES
                                         6.7.2.2.5. LOTIONS
                           6.7.2.3. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE
                                         6.7.2.3.1. SUPPOSITORIES
                                         6.7.2.3.2. POWDERS
       6.8. IMPLANTABLE DRUG DELIVERY, BY PRODUCT TYPE
                6.8.1. ACTIVE IMPLANTABLE DRUG DELIVERY DEVICES
                6.8.2. PASSIVE IMPLANTABLE DRUG DELIVERY DEVICES
       6.9. TRANSMUCOSAL DRUG DELIVERY, BY PRODUCT TYPE
                6.9.1. ORAL TRANSMUCOSAL DRUG DELIVERY, BY TYPE
                           6.9.1.1. BUCCAL DRUG DELIVERY
                           6.9.1.2. SUBLINGUAL DRUG DELIVERY
                6.9.2. OTHER TRANSMUCOSAL DRUG DELIVERY, BY TYPE
                           6.9.2.1. RECTAL TRANSMUCOSAL DRUG DELIVERY
                           6.9.2.2. TRANSMUCOSAL TRANSMUCOSAL DRUG DELIVERY

7. DRUG DELIVERY DEVICES MARKET, BY END-USER

       7.1. OVERVIEW
       7.2. HOSPITALS
       7.3. HOME HEALTHCARE
       7.4. CLINICS
       7.5. COMMUNITY HEALTHCARE
       7.6. OTHERS

8. DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL

       8.1. OVERVIEW
       8.2. HOSPITAL PHARMACIES
       8.3. PHARMACY STORES
       8.4. DIRECT TENDERS
       8.5. ONLINE PHARMACY

9. DRUG DELIVERY DEVICES MARKET, BY GEOGRAPHY

       9.1. COUNTRY WISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                9.1.1. NORTH AMERICA
                           9.1.1.1. U.S.
                           9.1.1.2. CANADA
                           9.1.1.3. MEXICO
                9.1.2. EUROPE
                           9.1.2.1. GERMANY
                           9.1.2.2. FRANCE
                           9.1.2.3. U.K.
                           9.1.2.4. ITALY
                           9.1.2.5. SPAIN
                           9.1.2.6. RUSSIA
                           9.1.2.7. TURKEY
                           9.1.2.8. BELGIUM
                           9.1.2.9. NETHERLANDS
                           9.1.2.10. SWITZERLAND
                           9.1.2.11. REST OF EUROPE
                9.1.3. ASIA-PACIFIC (APAC)
                           9.1.3.1. JAPAN
                           9.1.3.2. CHINA
                           9.1.3.3. SOUTH KOREA
                           9.1.3.4. INDIA
                           9.1.3.5. AUSTRALIA
                           9.1.3.6. SINGAPORE
                           9.1.3.7. THAILAND
                           9.1.3.8. MALAYSIA
                           9.1.3.9. INDONESIA
                           9.1.3.10. PHILIPPINES
                           9.1.3.11. REST OF APAC
                9.1.4. LATIN AMERICA
                           9.1.4.1. BRAZIL
                           9.1.4.2. REST OF LATIN AMERICA
                9.1.5. MIDDLE EAST AND AFRICA
                           9.1.5.1. SOUTH AFRICA
                           9.1.5.2. REST OF MIDDLE EAST AND AFRICA
       9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10. DRUG DELIVERY DEVICES MARKET: COMPETITIVE LANDSCAPE

       10.1. GLOBAL DRUG DELIVERY DEVICES MARKET: COMPANY SHARE ANALYSIS
       10.2. U.S. DRUG DELIVERY DEVICES MARKET: COMPANY SHARE ANALYSIS
       10.3. EUROPE DRUG DELIVERY DEVICES MARKET: COMPANY SHARE ANALYSIS
       10.4. APAC DRUG DELIVERY DEVICES MARKET: COMPANY SHARE ANALYSIS

11. DRUG DELIVERY DEVICES MARKET, COMPANY PROFILES

       11.1. BAYER AG
                11.1.1. COMPANY OVERVIEW
                11.1.2. REVENUE ANALYSIS
                11.1.3. PRODUCT PORTFOLIO
                11.1.4. RECENT DEVELOPMENTS
                11.1.5. DATA BRIDGE ANALYSIS
       11.2. JOHNSON & JOHNSON
                11.2.1. COMPANY OVERVIEW
                11.2.2. REVENUE ANALYSIS
                11.2.3. PRODUCT PORTFOLIO
                11.2.4. RECENT DEVELOPMENTS
                11.2.5. DATA BRIDGE ANALYSIS
       11.3. NOVARTIS AG
                11.3.1. COMPANY OVERVIEW
                11.3.2. REVENUE ANALYSIS
                11.3.3. PRODUCT PORTFOLIO
                11.3.4. RECENT DEVELOPMENTS
                11.3.5. DATA BRIDGE ANALYSIS
       11.4. PFIZER, INC.
                11.4.1. COMPANY OVERVIEW
                11.4.2. REVENUE ANALYSIS
                11.4.3. PRODUCT PORTFOLIO
                11.4.4. RECENT DEVELOPMENTS
                11.4.5. DATA BRIDGE ANALYSIS
       11.5. F. HOFFMANN-LA ROCHE AG
                11.5.1. COMPANY OVERVIEW
                11.5.2. REVENUE ANALYSIS
                11.5.3. PRODUCT PORTFOLIO
                11.5.4. RECENT DEVELOPMENTS
                11.5.5. DATA BRIDGE ANALYSIS
       11.6. GLAXOSMITHKLINE PLC
                11.6.1. COMPANY OVERVIEW
                11.6.2. REVENUE ANALYSIS
                11.6.3. PRODUCT PORTFOLIO
                11.6.4. RECENT DEVELOPMENTS
                11.6.5. DATA BRIDGE ANALYSIS
       11.7. MERCK & CO.
                11.7.1. COMPANY OVERVIEW
                11.7.2. REVENUE ANALYSIS
                11.7.3. PRODUCT PORTFOLIO
                11.7.4. RECENT DEVELOPMENTS
                11.7.5. DATA BRIDGE ANALYSIS
       11.8. ANTARES PHARMA, INC.
                11.8.1. COMPANY OVERVIEW
                11.8.2. REVENUE ANALYSIS
                11.8.3. PRODUCT PORTFOLIO
                11.8.4. RECENT DEVELOPMENTS
                11.8.5. DATA BRIDGE ANALYSIS
       11.9. 3M
                11.9.1. COMPANY OVERVIEW
                11.9.2. REVENUE ANALYSIS
                11.9.3. PRODUCT PORTFOLIO
                11.9.4. RECENT DEVELOPMENTS
                11.9.5. DATA BRIDGE ANALYSIS
       11.10. SANOFI
                 11.10.1. COMPANY OVERVIEW
                11.10.2. REVENUE ANALYSIS
                11.10.3. PRODUCT PORTFOLIO
                11.10.4. RECENT DEVELOPEMENTS
                11.10.5. DATA BRIDGE ANALYSIS
       11.11. NEMERA
                11.11.1. COMPANY OVERVIEW
                11.11.2. REVENUE ANALYSIS
                11.11.3. PRODUCT PORTFOLIO
                11.11.4. RECENT DEVELOPMENTS
                11.11.5. DATA BRIDGE ANALYSIS

12. APPENDIX

13. DISCLAIMER

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART